During the past decade, IMV Pesquisa Neurológica conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IMV Pesquisa Neurológica" are "Multiple Sclerosis" (2 trials), "Relapsing Multiple Sclerosis" (2 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "IMV Pesquisa Neurológica" in a lesser frequency.

Most popular intervention types in "IMV Pesquisa Neurológica" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Antihistamine" (2 trials), "Fenebrutinib" (2 trials), "Methylprednisolone" (2 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "IMV Pesquisa Neurológica" are 5 trials for "All" genders.

Currently, there are NaN active trials in "IMV Pesquisa Neurológica". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in IMV Pesquisa Neurológica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IMV Pesquisa Neurológica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".